<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ma</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Soloveva</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Warren</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.</article-title>
  <source>
   <italic>Antivir. Res.</italic>
  </source>
  <volume>150</volume>
  <fpage>112</fpage>–
  <lpage>122</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.12.008</pub-id>
  <?supplied-pmid 29253498?>
  <pub-id pub-id-type="pmid">29253498</pub-id>
 </mixed-citation>
</ref>
